Comment on Clinical Trial NCT00950001 and NCCTG/N107C/CEC.3: Are We Treating Cancer or Water?

HTML  XML Download Download as PDF (Size: 433KB)  PP. 12-15  
DOI: 10.4236/ijmpcero.2021.101002    403 Downloads   1,011 Views  
Author(s)

ABSTRACT

During the implementation of clinical trials NCT00950001 and NCCTG/N107C/CEC.3 on post-operative stereotactic radiosurgery into clinic, it brought us some thinking of fundamental concept in science that the local control rate and survival rate rely on the treatment of marginal region more than resection cavity. Marginal region might still contain residual cancer cell while the resection cavity contains only water fluid most time. Radiation treatment should focus more on the margin rather than the cavity, thus treating cancer rather than water.

Share and Cite:

Gao, J. (2021) Comment on Clinical Trial NCT00950001 and NCCTG/N107C/CEC.3: Are We Treating Cancer or Water?. International Journal of Medical Physics, Clinical Engineering and Radiation Oncology, 10, 12-15. doi: 10.4236/ijmpcero.2021.101002.

Cited by

No relevant information.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.